NATERA, INC. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum
NATERA, INC. (NTRA) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum of 4.18% for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-09.
Discontinued › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum · last filed 2023-11-09
- NATERA, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, maximum for the quarter ending 2016-09-30 was 1.12%, a 37.78% decline year-over-year.
- NATERA, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, maximum for the quarter ending 2016-06-30 was 1.24%, a 34.04% decline year-over-year.
- NATERA, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, maximum for the quarter ending 2016-03-31 was 1.51%, a 4.43% decline year-over-year.
- NATERA, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, maximum for the quarter ending 2015-09-30 was 1.80%, a 11.76% decline year-over-year.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum 9 month |
|---|---|---|---|
| 2023-09-30 | 4.18% 10-Q · filed 2023-11-09 | ||
| 2023-06-30 | 4.06% 10-Q · filed 2023-08-04 | ||
| 2022-09-30 | 3.15% 10-Q · filed 2023-11-09 | ||
| 2022-06-30 | 2.74% 10-Q · filed 2023-08-04 | ||
| 2016-09-30 | 1.12% 10-Q · filed 2016-11-14 | 1.24% 10-Q · filed 2016-11-14 | |
| 2016-06-30 | 1.24% 10-Q · filed 2016-08-11 | 1.24% 10-Q · filed 2016-08-11 | |
| 2016-03-31 | 1.51% 10-Q · filed 2016-05-13 | ||
| 2015-09-30 | 1.80% 10-Q · filed 2016-11-14 | 1.96% 10-Q · filed 2016-11-14 | |
| 2015-06-30 | 1.88% 10-Q · filed 2016-08-11 | 1.88% 10-Q · filed 2016-08-11 | |
| 2015-03-31 | 1.58% 10-Q · filed 2016-05-13 | ||
| 2014-09-30 | 2.04% 10-Q · filed 2015-11-13 | 2.09% 10-Q · filed 2015-11-13 | |
| 2014-06-30 | 1.94% 10-Q · filed 2015-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QUEST DIAGNOSTICS INC (DGX) | United States | $26.096B | 22.09 |
| LABCORP HOLDINGS INC. (LH) | United States | $25.060B | 22.60 |
| Guardant Health, Inc. (GH) | United States | $23.675B | -12.65 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |